Changing faces of hepatocellular carcinoma: East vs West

Teh-Ia Huo^{1

2

3}, Shu-Yein Ho^{2

4}, Po-Hong Liu⁵

Affiliations

¹ Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
² Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
³ Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
⁴ Division of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan, Taiwan.
⁵ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Comment

Teh-Ia Huo et al. Liver Int. 2021 Jun.

. 2021 Jun;41(6):1430-1431.

doi: 10.1111/liv.14753. Epub 2020 Dec 12.

Teh-Ia Huo^{1

2

3}, Shu-Yein Ho^{2

4}, Po-Hong Liu⁵

¹ Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.
² Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
³ Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
⁴ Division of Gastroenterology and Hepatology, Min-Sheng General Hospital, Taoyuan, Taiwan.
⁵ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

No abstract available

Keywords: HCC; diagnosis; prognosis.

Comment on

The changing scenario of hepatocellular carcinoma in Italy: an update.
Garuti F, Neri A, Avanzato F, Gramenzi A, Rampoldi D, Rucci P, Farinati F, Giannini EG, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Brunetto MR, Trevisani F; ITA.LI.CA study group. Garuti F, et al. Liver Int. 2021 Mar;41(3):585-597. doi: 10.1111/liv.14735. Epub 2020 Dec 2. Liver Int. 2021. PMID: 33219585